Solriamfetol for binge eating disorder
Treatments studied
Part of Mental health clinical trials.
This study tests whether a drug called solriamfetol can help reduce binge eating episodes. It works on brain chemicals involved in mood and appetite control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of binge eating disorder (BED) based on the DSM-5 manual.
- You are between 18 and 55 years old.
- You have never taken the study drug solriamfetol (also called Sunosi) before.
- You are willing and able to follow all study procedures.
- Your doctor thinks it is safe for you to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the long-term safety and effectiveness of the medication solriamfetol for people with binge eating disorder. If you were in the earlier SOL-BED-301 study, this gives you a chance to continue treatment and see how it works over a longer time.
This trial tests whether a medication (liraglutide) plus behavioral counseling helps people with severe obesity and binge-eating disorder reduce binge episodes, lose weight, and improve coping. Participants will receive either liraglutide or placebo, along with group therapy sessions.
This trial tests if tirzepatide (a weekly injection) can help reduce binge eating compared to a placebo or another medication (lisdexamfetamine dimesylate). It may be a good fit for people with moderate or severe binge eating disorder who also have a high body weight.
This trial studies how binge eating disorder behaves during treatment and compares patterns over time. It may help by improving future treatment approaches for people with binge eating disorder.
This trial tests three levels of psychotherapy (high, medium, and low intensity) to find which works best for binge eating disorder. It aims to help you stop binge episodes and improve your relationship with food.
This Phase 2 trial tests whether oxytocin (a hormone-like medication) can reduce binge-eating symptoms in adults with binge-eating disorder (including related conditions like bulimia or certain feeding/eating disorders). You may be eligible if your symptoms match the trial’s specific diagnosis rules and you can safely take the study medication.
Hear when a new Binge-Eating Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.